Innate immune control of HIV

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 7, 2012, Pages

  Carrington, Mary ^a,b   Alter, Galit ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 15; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; NEF PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KIR3DL1 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; IMMUNOLOGICAL MEMORY; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; INNATE IMMUNITY; REVIEW; VIREMIA; VIROGENESIS; VIRUS REPLICATION; HUMAN; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; PHYSIOLOGY;

CYTOKINES; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; RECEPTORS, KIR; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DS1; VIRUS REPLICATION;

EID: 84876322820     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007070     Document Type: Review

References (94)

1. Allen TM, O'Connor DH, Jing P, Dzuris JL, Mothe BR, Vogel TU, Dunphy E, LieblME, Emerson C, Wilson N, et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-390.
2. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, StreeckH, Waring M, Meier A, Brander C, et al. 2007a. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204: 3027-3036.
3. Alter G, Teigen N, Ahern R, Streeck H, Meier A, Rosenberg ES, Altfeld M. 2007b. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 195: 1452-1460.
4. + NK cells during acute human immunodeficiency virus type 1 infection. J Virol 83: 6798-6805.
5. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, Oniangue-Ndza C, Martin M, Li B, Khakoo SI, et al. 2011. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476: 96-100.
6. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, FrassatiC, Reviron D, Middleton D, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
7. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
8. Barber LD, Percival L, Arnett KL, Gumperz JE, Chen L, Parham P. 1997. Polymorphism in the α 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J Immunol 158: 1660-1669.
9. Bashirova AA, Martin MP, McVicar DW, Carrington M. 2006. The killer immunoglobulin-like receptor gene cluster: Tuning the genome for defense. Annu Rev Genomics Hum Genet 7: 277-300.
10. Beignon AS, McKenna K, Skoberne M, Manches O, Dasilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115: 3265-3275.
11. Biron CA. 1999. Initial and innate responses to viral infections-Pattern setting in immunity or disease. Curr Opin Microbiol 2: 374-381.
12. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
13. Brennan J, Mager D, Jefferies W, Takei F. 1994. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 180: 2287-2295.
14. Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P. 2009. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113: 2434-2441.
15. Carrington M, Norman P. 2003. The KIR gene cluster. NCBI, Bethesda, MD.
16. Carrington M, O'Brien SJ. 2003. The influence of HLA genotype on AIDS. Annu Rev Med 54: 535-551.
17. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. 1994. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180: 1235-1242.
18. Cerboni C, Neri F, Casartelli N, Zingoni A, Cosman D, Rossi P, Santoni A, DoriaM. 2007. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 88: 242-250.
19. Cerwenka A, Lanier LL. 2001a. Ligands for natural killer cell receptors: Redundancy or specificity. Immunol Rev 181: 158-169.
20. Cerwenka A, Lanier LL. 2001b. Natural killer cells, viruses and cancer. Nat Rev Immunol 1: 41-49.
21. Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM, Guardiola J, Moretta A, Moretta L. 1992. Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: Definition of five distinct NK-determined allospecificities in humans. J Exp Med 175: 709-718.
22. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
23. Correa I, Raulet DH. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2: 61-71.
24. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
25. Dorfman JR, Raulet DH. 1996. Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol 26: 151-155.
26. Dorfman JR, Raulet DH. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med 187: 609-618.
27. Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, Cazaly A, Stathopoulos S, Middleton D, Mulder A, Claas FH, et al. 2010. Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci 107: 10160-10165.
28. Fan QR, Long EO, Wiley DC. 2001. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2: 452-460.
29. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
30. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
31. Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R, VilchesC, Parham P. 2001. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166: 2992-3001.
32. Hanke T, Raulet DH. 2001. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J Immunol 166: 3002-3007.
33. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, Miller JD, Altman JD, Liu Y, Cado D, Lemonnier FA, et al. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
34. Hanke T, Takizawa H, Raulet DH. 2001. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: Evidence for a regulated sequential model. Eur J Immunol 31: 3370-3379.
35. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, LipfordG, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
36. Held W, Dorfman JR, Wu MF, Raulet DH. 1996. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol 26: 2286-2292.
37. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. 2002. Killer Ig-like receptor haplotype analysis by gene content: Evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169: 5118-5129.
38. Jennes W, Verheyden S, Demanet C, Adje-Toure CA, Vuylsteke B, NkengasongJN, Kestens L. 2006. Cutting edge: Resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 177: 6588-6592.
39. Karre K. 2002. NK cells, MHC class I molecules and the missing self. Scand J Immunol 55: 221-228.
40. Karre K, Ljunggren HG, Piontek G, Kiessling R. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
41. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, FrenchAR, Sunwoo JB, Lemieux S, Hansen TH, et al. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
42. Kim S, Sunwoo JB, Yang L, Choi T, Song YJ, French AR, Vlahiotis A, Piccirillo JF, Cella M, Colonna M, et al. 2008. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci 105: 3053-3058.
43. Lanier LL. 1998. NK cell receptors. Annu Rev Immunol 16: 359-393.
44. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
45. Lee SH, Girard S, Macina D, Busa M, Zafer A, Belouchi A, Gros P, Vidal SM. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 28: 42-45.
46. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, HeardJM, Schwartz O. 1998. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8: 483-495.
47. Ljunggren HG, Karre K. 1990. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 11: 237-244.
48. Ljunggren HG, Van Kaer L, Ploegh HL, Tonegawa S. 1994. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci 91: 6520-6524.
49. Lodoen MB, Lanier LL. 2005. Viral modulation of NK cell immunity. Nat Rev Microbiol 3: 59-69.
50. Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, BarbourJD. 2008. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol 82: 4785-4792.
51. Maenaka K, Juji T, Nakayama T, Wyer JR, Gao GF, Maenaka T, Zaccai NR, KikuchiA, Yabe T, Tokunaga K, et al. 1999. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem 274: 28329-28334.
52. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267: 1016-1018.
53. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, HootsK, Vlahov D, Trowsdale J, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 429-434.
54. Martin MP, Bashirova A, Traherne J, Trowsdale J, Carrington M. 2003. Cutting edge: Expansion of the KIR locus by unequal crossing over. J Immunol 171: 2192-2195.
55. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733-740.
56. Martinelli E, Cicala C, Van Ryk D, Goode DJ, Macleod K, Arthos J, Fauci AS. 2007. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci 104: 3396-3401.
57. Maxwell LD, Wallace A, Middleton D, Curran MD. 2002. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60: 254-258.
58. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, LindsayRJ, Orellana L, Mildvan D, et al. 2009. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15: 955-959.
59. Moesta AK, Abi-Rached L, Norman PJ, Parham P. 2009. Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes. J Immunol 182: 3628-3637.
60. Moesta AK, Graef T, Abi-Rached L, Older Aguilar AM, Guethlein LA, Parham P. 2010. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J Immunol 185: 4233-4237.
61. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, BarbaresiM, Ciccone E, Moretta L. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 178: 597-604.
62. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. 2002. What is a natural killer cell? Nat Immunol 3: 6-8.
63. Murphy K, Travers P, Walport M. 2011. Janeway's immunobiology, 8th ed. Garland Science, New York.
64. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW. 2001. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52: 195-205.
65. Pantaleo G, Demarest JF, Schacker T, Vaccarezza M, Cohen OJ, Daucher M, Graziosi C, Schnittman SS, Quinn TC, Shaw GM, et al. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci 94: 254-258.
66. Peruzzi M, Parker KC, Long EO, Malnati MS. 1996. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 157: 3350-3356.
67. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, BrummeCJ, Pulit SL, Carrington M, et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
68. Rajagopalan S, Long EO. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 185: 1523-1528.
69. Raulet DH. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790.
70. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155: 41-52.
71. Ravet S, Scott-Algara D, Bonnet E, Tran HK, Tran T, Nguyen N, Truong LX, Theodorou I, Barre-Sinoussi F, Pancino G, et al. 2007. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 109: 4296-4305.
72. Salcedo M, Andersson M, Lemieux S, Van Kaer L, Chambers BJ, Ljunggren HG. 1998. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur J Immunol 28: 1315-1321.
73. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2: 338-342.
74. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P. 2002. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 168: 2307-2315.
75. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719-3733.
76. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagne F, Ferracci G, Arosa FA, et al. 2005. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci 102: 13224-13229.
77. Storkus WJ, Alexander J, Payne JA, Cresswell P, Dawson JR. 1989a. The α1/α2 domains of class I HLA molecules confer resistance to natural killing. J Immunol 143: 3853-3857.
78. Storkus WJ, Alexander J, Payne JA, Dawson JR, Cresswell P. 1989b. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Natl Acad Sci 86: 2361-2364.
79. + T cells. Retrovirology 6: 42.
80. Thomas R, Apps R, Qi Y, Gao X, Male V, O'hUigin C, O'Connor G, Ge D, Fellay J, Martin JN, et al. 2009. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 41: 1290-1294.
81. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763.
82. Vales-Gomez M, Reyburn H, Strominger J. 2000. Interaction between the human NK receptors and their ligands. Crit Rev Immunol 20: 223-244.
83. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'AndreaA, Phillips JH, Lanier LL, Parham P. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
84. Vilches C, Parham P. 2002. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20: 217-251.
85. Vitale M, Sivori S, Pende D, Moretta L, Moretta A. 1995. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc Natl Acad Sci 92: 3536-3540.
86. Wende H, Colonna M, Ziegler A, Volz A. 1999. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13. 4. Mamm Genome 10: 154-160.
87. Wilson MJ, Torkar M, Haude A, Milne S, Jones T, Sheer D, Beck S, Trowsdale J. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci 97: 4778-4783.
88. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT. 1999. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 68: 1784-1789.
89. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. 2006. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203: 633-645.
90. Yokoyama WM. 2002. The search for the missing "missing-self" receptor on natural killer cells. Scand J Immunol 55: 233-237.
91. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM. 1990. Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1. 1 antigen. J Immunol 145: 2353-2358.
92. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. 2007. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 179: 5977-5989.
93. Zappacosta F, Borrego F, Brooks AG, Parker KC, Coligan JE. 1997. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci 94: 6313-6318.
94. Zhang C, Zhang J, Wei H, Tian Z. 2005. Imbalance of NKG2D and its inhibitory counterparts: How does tumor escape from innate immunity? Int Immunopharmacol 5: 1099-1111.